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Abstract	  	   	   	   The	   synthesis	   and	   functionalization	   of	   pharmaceutically	   useful	   compounds	  has	   long	   been	   a	   major	   focus	   in	   organic/medicinal	   chemistry.	   Post-­‐synthetic	  alkylation	  of	  target	  compounds	  is	  a	  topic	  of	  strong	  interest	  to	  the	  pharmaceutical	  community.	   In	   light	   of	   this,	   the	   project	   focus	   is	   on	   designing	   metal-­‐free	  conditions	  to	  alkylate	  heteroarenes	  using	  readily	  available	  alcohols.	  In	  the	  classic	  Minisci	  reaction,	  alcohol	  addition	  to	  heteroarenes	  results	  in	  a	  remaining	  alcohol	  within	  the	  product.	  Alternatively,	  a	  gamma	  radiation-­‐based	  procedure	  allows	  for	  a	  spin-­‐center	  shift	  mechanism	  that	  provides	  the	  alcohol	  free	  alkylation	  product.	  Recently,	   a	   photoredox	   approach	   using	   an	   iridium	   catalyst	   has	   also	   been	  developed	   to	   carry	   out	   this	   alkylation.	   The	   requirement	   of	   an	   iridium	  photocatalyst	   and	   the	   need	   for	   removal	   of	   the	   toxic	   iridium	   metal	   before	  biological	   testing,	   establishes	   a	   need	   for	   metal-­‐free	   versions	   of	   this	  transformation.	   In	   this	   project,	  we	   have	   invented	   a	   new,	   alkylation	   reaction	   of	  heteroarenes	  with	  alcohols,	  under	  metal-­‐free	  conditions	  via	  a	  peroxide-­‐mediated	  radical	   mechanism.	   Importantly,	   we	   have	   demonstrated	   that	   our	   new	  method	  can	   alkylate	   isoquinoline,	   quinoline,	   2,6-­‐lutidine	   and	   4-­‐tButylpyridine	  derivatives	  without	  metal	  catalysts	  and	  with	  a	  variety	  of	  alcohols.	  In	  conclusion,	  our	   protocol	   enables	   access	   to	   diverse	   alkylated	   drug	   derivatives	   under	   mild	  conditions,	   with	   the	   promise	   for	   divergent	   functionalizations	   of	   heteroarenes	  with	  important	  pharmaceutical	  applications.	  
	  
	  
Introduction	  	   	   	   	   Heterocycle	  is	  classified	  as	  a	  cyclic	  compound	  with	  more	  than	  two	  types	  of	  element	   as	   members	   in	   its	   ring.	   Heterocycles	   are	   commonly	   presented	   in	   the	  pharmaceutical	   compounds	  of	  popular	   applications.	  Among	   these	  heterocycles,	  92%	  are	  nitro-­‐containing	  heterocycles,	  where	  N-­‐Heterocycles	  are	  considered	  as	  the	  biggest	  candidate	  for	  drugs	  (Figure	  1).	  	  
	  
















Figure	  2	  :	  Heteroarene-­‐containing	  drugs	  	  	   	   	   Functionalizations	   of	   drugs	   can	   improve	   their	   potency.	   One	   of	   the	  functionalizing	   methods	   is	   through	   post-­‐synthetic	   alkylation.	   This	   type	   of	  functionalization	   for	   potency	   improvement	   is	   demonstrated	   as	   Methyl	   Effect2.	  Methylation	   is	   useful	   in	   optimizing	   properties	   of	   drug	   candidates	   that	   can	  significantly	  improve	  the	  IC50	  (Figure	  3).	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diphenyl amide inhibitor of p38α kinase
	   	   	   One	  pathway	  to	  improve	  potency	  is	  to	  increase	  drug’s	  biological	  activity2.	  The	  methylation	   provides	   alternative	   oxidation	   of	   the	   anti-­‐inflammatory	   drugs	  (Figure	  4).	  Through	  a	  normal	  pathway,	  the	  highlight	  thiozole	  group	  in	  Sudoxicam	  can	  be	  oxidized	  with	  enzyme	  CYP2C9.	  The	  pertinent	  decomposition	  resulted	   in	  the	  loss	  of	  its	  potency.	  Alternatively,	  the	  methylated	  Sudoxicam	  (Meloxicam)	  has	  a	  higher	  resistant.	  The	  pertinent	  product	  of	  oxidation	  is	  the	  alcohol	  that	  retains	  its	  potency	  as	  anti-­‐inflammatory	  drug.	   	  
	  	  





































pronated	   on	   Nitrogen	   atom	   and	   becomes	   electrophilic	   readily	   for	  nucleophilically	   radical	   addition.	   The	   alklated	   product	   is	   formed	   after	   the	  addition	  of	  alkyl	  radial	  to	  aromatic	  ring,	  which	  is	  followed	  by	  further	  oxidation,	  elimination	  and	   rearomatization	  of	   the	  pertinent	   cation	   radical	   (Figure	  5).	  The	  alkyl	  radical	  can	  be	  introduced	  by	  many	  means.	   	  
	  
Figure	  5	  :	  Mechanism	  of	  Minisci	  reaction4	  	  One	   of	   the	   pathways	   is	   the	   cleavage	   from	   dimethyl	   sulfoxide	   (DMSO)	   with	  Fenton’s	   reagents	   (Figure	  6).	  However,	   this	   condition	   is	   limited	   to	  methylation	  with	  the	  use	  of	  metal,	  which	  calls	  for	  a	  need	  for	  metal-­‐free	  alkylation	  with	  more	  available	  alkylating	  sources.	   	  
	  





































Figure	  7	  :	  Enzyme-­‐catalyzed	  RNA	  deoxygenation	  The	  alkyl	  radical	  is	  formed	  from	  deoxygenation	  of	  alcohols	  (Figure	  8).	  In	  order	  to	  obtain	   the	   alkyl	   radical,	   the	   alcohol	   radical	   firstly	   formed	   after	   reduction	   or	  Hydrogen	   Atom	   Transfer	   (HAT).	   The	   removal	   of	   water	   introduces	   the	  carbocation.	   In	   order	   to	   stabilize	   this	   carbocation,	   the	   radical	   or	   the	   unpaired	  electron	   shifts	   to	   the	   positive	   charged	   carbon.	   The	   pertinent	   carbocation	   is	  stabilized	  by	  further	  elimination.	  The	  alkyl	  radical	  is	  formed	  via	  SCS	  pathway.	   	  
	  






























X = N, or O
	   	   	   The	  goal	  of	  this	  project	  is	  to	  develop	  a	  novel	  alkylation	  of	  heteroarenes	  using	  readily	   available	   alcohols	   under	   metal-­‐free	   condition	   (Figure	   9).	   In	   this	  alkylation,	   the	   role	   of	   metal	   is	   replaced	   by	   heating,	   where	   oxidant	   radical	   is	  formed	  from	  the	  homolysis	  of	  pertinent	  peroxide.	  Different	  chemical	  conditions	  have	  been	  investigated	  as	  shown	  in	  Experimental	  Approaches.	   	  	  
	  









Figure	  10	  :	  Divergent	  additions	  of	  heteroarene	  	  
Experimental	  Approaches	  	   	   	   The	  investigation	  of	  interest	  is	  the	  alkylation	  of	  an	  N-­‐heteroarene	  derivative	  that	   is	   the	   biggest	   candidate	   for	   drugs.	   Successful	   alkylation	   of	   isoquinoline	   is	  observed	  via	  a	  peroxide-­‐intermediated	  pathway	  by	  Jeremy	  Lear	  (Figure	  11).	   	  	  
	  

























pertinent	  cation	  radical,	  α-­‐hydrogen	  is	  transferred	  to	  nitrogen	  and	  this	  cation	  is	  neutralized	  with	  further	  elimination.	  An	  α-­‐hydroxyl	  radical	  with	  SCS	  character	  is	  formed	   after	  Hydrogen	  Atom	  Transfer	   (HAT)	   and	   removal	   of	   hydrogen	   cation.	  Similar	   with	   alcohol	   radicals	   in	   RNA,	   this	   radical	   is	   deoxygenated	   via	   SCS	  pathway	   to	   introduce	   the	   new	   radical.	   At	   last,	   alkylated	   product	   is	   formed	   by	  propagating	   incoming	   alcohols.	   This	   propagation	   also	   provides	   new	   alcohol	  radicals	   for	   further	   SCS	   alkylation	   (Figure	   12).	   	   This	   concept	   is	   called	  Spin-­‐Center	  Shift	  alkylation	  or	  SCS	  alkylation	  for	  short.	  	  
	  












































	   	   	   	   In	   the	   heteroarene	   derivatives	   of	   commercial	   pharmaceuticals,	   the	  2-­‐positions	  are	  usually	  substituted	  and	  leaves	  4-­‐position	  available	  for	  alkylation,	  like	  Camptochecin	  (Figure	  2).	  Based	  on	  this	  factor,	  2,6-­‐lutidine	  with	  2-­‐positions	  substituted	   is	   investigated	   with	   SCS	   alkylation	   (Table	   1).	   In	   the	   reaction,	  p-­‐toluenesulfonic	   (PTSA)	   acid	   was	   used	   to	   activate	   the	   2,6-­‐lutidine,	   tert-­‐butyl	  peroxide	   as	   oxidant,	   dimethyl	   sulfoxide	   (DMSO)	   as	   solvent,	   and	   propanol	   as	  alkylating	   sources.	   The	   formation	   of	   4-­‐propyl-­‐2,6-­‐lutidine	   is	   observed	   with	   a	  trend	   that	   longer	   reaction	   period	   and	   more	   acidic	   condition	   provide	   higher	  yields.	  Based	  on	  the	  mechanism	  of	  Minisci	  reaction,	  the	  formation	  of	  methylated	  product	   is	   also	  expected	  due	   to	   the	  present	  of	  DMSO.	  However,	  no	  methylated	  product	   is	   observed.	   This	   result	   can	   b	   explained	   that	   the	   formation	   of	   alcohol	  radical	   is	   more	   favorable	   than	   the	   formation	   of	   methyl	   radical	   under	   the	  conducted	   condition,	   where	   the	   alcohol	   radical	   could	   be	   stabilized	   by	   its	  resonances.	   	  
	  Trial	   (tBuO)2(eq.)	   PTSA(eq.)	   Time(h)	   SM(%)	   Target(%)	  
1	   1.0	   0.4	   18	   62.9	   37.1	  2	   1.0	   1.0	   10	   50.0	   50.0	  3	   1.0	   1.0	   18	   41.2	   58.8	  







	   	   	   Based	  on	  the	  proposed	  mechanism	  (Figure	  12)	  ,	  one	  of	  the	  by-­‐products	  is	  the	  Minisci-­‐type	  product	  with	  hydroxyl	  group.	  In	  Minisci	  reaction,	  excessed	  peroxide	  is	   usually	   used	   to	   complete	   late-­‐stage	   oxidation.	   The	   key	   of	   successful	   SCS	  alkylation	  instead	  of	  Minisci	  reaction	  is	  to	  use	  critical	  amount	  of	  peroxides.	  The	  expected	   peroxide	   can	   both	   initiate	   and	   direct	   reaction	   to	   a	   SCS	   alkylation	  pathway.	  From	   the	  experimental	   result,	  peroxide	  with	  one	  molar	  equivalent	   to	  substrate	   provides	   the	   highest	   yield	   of	   target.	   In	   addition,	   no	   Minisci-­‐type	  product	  is	  observed	  in	  1H	  NMR	  spectrum.	  	   	   	   In	   light	   of	   divergent	   reaction	   pathways,	   the	   product	   data	   of	   13C	   NMR	   and	  DEPT	   13C	  NMR	  are	  used	   to	   confirm	   the	   formation	  of	  4-­‐propyl-­‐2,6-­‐lutidine.	  The	  peak	   at	   38	   ppm	   is	   corresponding	   to	   the	   carbon	   connecting	   to	   aromatic	   ring,	  which	   carbon	   has	   two	   hydrogen	   atoms	   in	   SCS	   alkylated	   product	   and	   one	  hydrogen	  atom	  in	  Minisci-­‐type	  products.	  In	  the	  spectrum	  of	  DEPT	  13C	  NMR,	  this	  peak	  is	  downward	  that	   indicates	  the	  present	  of	  CH2	  group.	  Thus,	  2,6-­‐lutidine	  is	  alkylated	  via	  SCS	  alkylation.	  	   	   	   Motifs	  for	  followed	  investigation	  is	  the	  fact	  that	  heteroarenes	  are	  substituted	  by	   electron-­‐withdrawing	   groups	   in	   many	   drug	   compounds.	   As	   a	   result,	   the	  aromatic	   ring	   becomes	   even	   more	   electron-­‐deficient.	   An	   interest	   raised	   that	  whether	   SCS	   alkylation	   is	   able	   to	   alkylate	   these	   heteroarenes.	   4-­‐cyanopyridine	  was	   tested	   as	   electron	   poorer	   N-­‐heteroarenes	   (Table	   2).	   Acidity	   is	   tested	   as	   a	  control	   to	   optimize	   the	   reactivity	   of	   4-­‐cyanopyridine	   with	   SCS	   alkylation.	  However,	  no	  target	  molecule	  was	  observed.	  What	  is	  more,	  n-­‐propyl	  isonicotinate	  
is	   formed	   and	   characterized	   under	   this	   condition.	   The	   cyanide	   group	   was	  hydrolyzed	   and	   esterified	   with	   n-­‐propanol	   under	   acidic	   condition	   at	   high	  temperature.	  
	  Trial	   (tBuO)2(eq.)	   PTSA(eq.)	   Time(h)	   Yield(%)	  1	   1	   0.2	   7	   0	  2	   1	   0.2	   22	   0	  3	   1	   0.4	   7	   0	  4	   1	   0.6	   7	   0	  









ring	  and	  also	  contribute	  to	  selectivity	   in	  alkylation	  (Figure	  13).	  The	  bulky	  alkyl	  group,	   like	   isopropyl	   group,	   on	   nitrogen	   increases	   steric	   hindrance	   on	  2-­‐positions,	  resulting	  a	  major	  formation	  of	  4-­‐Alkyalted	  product	  (Figure	  14).	  The	  2-­‐	   or	   4-­‐alkylated	   products	   are	   formed	   after	   further	   removal	   of	   this	   activating	  group.	  
	  
Figure	  13	  :	  Proposal	  for	  selectivity	  of	  2-­‐alkylated	  product	  
	  
Figure	  14	  :	  Proposal	  for	  selectivity	  of	  4-­‐alkylated	  product	  	   	   	   	   	   	   	   	   The	   alternative	   activations	  were	   investigated	   on	   2,6-­‐lutidine.	   Formation	   of	  N-­‐oxide	   (Figure	   15)	   was	   observed.	   In	   order	   to	   complete	   activating	   and	  deactivating	  circle,	  basic	  deoxygenation6	  (Figure	  16)	  was	  tested	  on	  N-­‐oxide	  alkyl	  2,6-­‐lutidine	  (Figure	  17).	   	  
	   	   	   	   	   	  

































	   	   	  
Figure	  16	  :	  Deoxygenation	  under	  basic	  conditions	  
	   	   	   	   	  
Figure	  17	  :	  Base-­‐mediated	  deoxygenation	  of	  N-­‐oxide	  	   	   	   However,	   only	  N-­‐oxide	  was	   observed	  by	   1H	  NMR	   spectrum	  and	  Thin	  Layer	  Chromatography	   (TLC)	   plate	   analysis.	   Other	   combinations	   of	   base	   and	   solvent	  will	  be	  used	  for	  further	  investigation.	  Formation	  of	  N-­‐alkyl	  lutidinium	  (Table	  3)	  was	  observed.	  
	   	   	   	   	   	  Trial	   R	   Time	  (h)	   Yield(%)	  1	   isopropyl	   13	   0	  2	   isopropyl	   44	   0	  3	   ethyl	   13	   80	  






















Figure	  18	  :	  Hoffman	  elimination	  
	  
Summary	  	   	   	   SCS	  method	  provides	  a	  metal-­‐free	  alkylation	  of	  heteroarenes	  using	  alcohols.	  Our	   recent	   investigations	   have	   demonstrated	   successful	   alkylation	   of	  isoquinoline,	   quinoline,	   2,6-­‐lutidine	   and	   4-­‐tButylpyridine	   (Figure	   19).	   These	  studies	   were	   carried	   out	   with	   Jeremy	   Lear	   and	   Ani	   Mustafa.	   Alternative	  activation	  of	  heteroarenes	  with	  selectivity	  is	  being	  investigated	  (Figure	  20).	  
	  
Figure	  19	  :	  Substrate	  scope	  of	  successful	  SCS	  alkylation	  (with	  Jeremy	  and	  Ani)	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Figure	  20	  :	  Alternative	  activation	  of	  SCS	  alkylation	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General	   Procedure:	   A	   solution	   of	   2,6-­‐lutidine	   (50	   mg,	   0.47	   mmol),	  p-­‐Toluenesulfonic	  acid	  (0.0925	  g,	  0.19	  mmol),	  DMSO	  (0.5	  mL)	  and	  nPrOH	  (1.0	  ml,	  13.36	   mmol)	   were	   mixed	   in	   a	   8-­‐mL	   screw	   thread	   vial	   and	   degased	   via	  Freeze-­‐Pump-­‐Thaw.	   (tBuO)2	  was	  added	   last	   to	   the	  mixture	  under	  purging	  with	  N2.	  The	  reaction	  vial	  than	  was	  transferred	  to	  a	  pre-­‐heated	  hot	  plate	  and	  ran	  for	  8	  hours	  at	  135	  °C.	  	  
General	   Work-­‐Up:	   Sodium	   bicarbonate	   was	   used	   to	   neutralized	   the	   reaction	  mixture	   to	  a	  pH	  of	  8	  –	  9.	  To	  a	   separatory	   funnel,	  10	  mL	  of	  distilled	  water	  was	  added.	  Dichloromethane	  (3	  ×	  10	  mL)	  was	  used	  to	  wash	  the	  reaction	  mixture	  to	  extract	  product	  from	  aqueous	  layer	  into	  organic	  layer.	  The	  alkylated	  product	  was	  isolated	  through	  column.	  	  	  
4-­‐propyl-­‐2,6-­‐lutidine	  
	  







1H	  NMR	  (400	  MHz,	  CDCl3)	  δ	  8.77	  (m,	  2H),	  7.84	  (m,	  2H),	  4.31	  (t,	  2H),	  1.80	  (m,	  2H),	  1.03	  (t,	  3H).	  13C	  NMR	  (400	  MHz,	  CDCl3)	  δ	  165.73,	  150.59,	  137.61,	  122.84,	  67.35,	  22.00,	  10.44	  ppm.	  	  
	  1H	  NMR	  spectrum	  of	  4-­‐propyl-­‐2,6-­‐lutidine	  	  	  	  	  	  	  	  
	  13C	  NMR	  spectrum	  of	  4-­‐propyl-­‐2,6-­‐lutidine	  	  
	  DEPT	  13C	  NMR	  spectrum	  of	  4-­‐propyl-­‐2,6-­‐lutidine	  	  	  	  
	  Mass	  spectrum	  of	  4-­‐propyl-­‐2,6-­‐lutidine	  	  	  	  	  	  	  
	  IR	  spectrum	  of	  4-­‐propyl-­‐2,6-­‐lutidine	  	  	  	  	  	  
	  1H	  NMR	  spectrum	  of	  n-­‐Propyl	  Isonicotinate	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  NMR	  spectrum	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  n-­‐Propyl	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